FDG PET in Prostate Cancer

被引:34
|
作者
Jadvar, Hossein [1 ]
机构
[1] Univ Southern Calif, Keck Sch Med, Dept Radiol, Div Nucl Med, 2250 Alcazar St,CSC 102, Los Angeles, CA 90033 USA
基金
美国国家卫生研究院;
关键词
PET; CT; FDG; Prostate; Cancer;
D O I
10.1016/j.cpet.2009.05.002
中图分类号
R8 [特种医学]; R445 [影像诊断学];
学科分类号
1002 ; 100207 ; 1009 ;
摘要
The role of positron emission tomography (PET) with [F-18]-fluorodeoxyglucose (FDG) for the imaging evaluation of patients who have cancer has expanded rapidly worldwide. The exact clinical use of PET and PET-computed tomography in prostate cancer is currently being explored. The recent publications summarizing the NOPR findings showed that prostate cancer was one of the most common cancers with patient enrollment. This article first reviews the limited available data on the molecular biology basis of FDG accumulation in prostate cancer, and then briefly reviews the current clinical experience with the use of PET with FDG in the imaging evaluation of prostate cancer.
引用
收藏
页码:155 / +
页数:8
相关论文
共 50 条
  • [1] FDG PET/CT Demonstration of Pancreatic Metastasis From Prostate Cancer
    Desai, Bhushan
    Elatre, Wafaa
    Quinn, David I.
    Jadvar, Hossein
    CLINICAL NUCLEAR MEDICINE, 2011, 36 (10) : 961 - 962
  • [2] FDG PET in suspected recurrent and metastatic prostate cancer
    Jadvar, H
    Pinski, JK
    Conti, PS
    ONCOLOGY REPORTS, 2003, 10 (05) : 1485 - 1488
  • [3] Utility of FDG-PET in clinical neuroendocrine prostate cancer
    Spratt, Daniel E.
    Gavane, Somali
    Tarlinton, Lisa
    Fareedy, Shoaib B.
    Doran, Michael G.
    Zelefsky, Michael J.
    Osborne, Joseph R.
    PROSTATE, 2014, 74 (11) : 1153 - 1159
  • [4] High-grade urothelial carcinoma of the prostate on FDG PET-CT
    Ho, Linh
    Quan, Vicki
    Henderson, Robert
    Seto, John
    CLINICAL NUCLEAR MEDICINE, 2007, 32 (09) : 746 - 747
  • [5] Molecular Imaging of Prostate Cancer: PET Radiotracers
    Jadvar, Hossein
    AMERICAN JOURNAL OF ROENTGENOLOGY, 2012, 199 (02) : 278 - 291
  • [6] Diagnostic Performance of 11C-choline PET/CT and FDG PET/CT in Prostate Cancer
    Kitajima, Kazuhiro
    Yamamoto, Shingo
    Odawara, Soichi
    Kobayashi, Kaoru
    Fujiwara, Masayuki
    Kamikonya, Norihiko
    Fukushima, Kazuhito
    Nakanishi, Yukako
    Hashimoto, Takahiko
    Yamada, Yusuke
    Suzuki, Toru
    Kanematsu, Akihiro
    Nojima, Michio
    Yamakado, Koichiro
    ACTA MEDICA OKAYAMA, 2018, 72 (03) : 289 - 296
  • [7] MRI and FDG PET/CT Findings of Malignant Fibrous Histiocytoma of the Prostate
    Dong, Aisheng
    Gong, Jing
    Wang, Yang
    Zuo, Changjing
    CLINICAL NUCLEAR MEDICINE, 2014, 39 (10) : 889 - 891
  • [8] Focal Autoimmune Pancreatitis Mimicking Pancreatic Cancer on FDG PET/CT Imaging
    Zheng, Lichun
    Xing, Haiqun
    Li, Fang
    Huo, Li
    CLINICAL NUCLEAR MEDICINE, 2018, 43 (01) : 57 - 59
  • [9] Molecular Imaging of Prostate Cancer with PET
    Jadvar, Hossein
    JOURNAL OF NUCLEAR MEDICINE, 2013, 54 (10) : 1685 - 1688
  • [10] Comparison of FDG PET/MRI and FDG PET/CT in Pediatric Oncology in Terms of Anatomic Correlation of FDG-positive Lesions
    Uslu-Besli, Lebriz
    Kapucu, Lutfiye Ozlem Atay
    Karadeniz, Ceyda
    Akdemir, Umit Ozgur
    Pinarli, Faruk Guclu
    Aydos, Uguray
    Okur, Arzu
    Kaya, Zuhre
    Samanci, Cesur
    Karabacak, Nese I.
    JOURNAL OF PEDIATRIC HEMATOLOGY ONCOLOGY, 2019, 41 (07) : 542 - 550